HyaRegen Gel
Commercial- Indications
- Tissue repair, Wound healing
Company intelligence / Profile preview
BioRegen Biomedical has developed and commercialized a range of advanced biomaterial products for wound repair and postoperative functional healing in ENT, gynecology, and general surgery. Their products are available internationally across Asia, Europe, the Americas, the Middle East, and South America. Key product launches include Class II/III ENT devices and intrauterine cavity gels such as "MateRegen Gel" and the independent brand "VitRegen".
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioRegen Biomedical.